High expression of ETS2 predicts poor prognosis in acute myeloid leukemia and may guide treatment decisions

High expression of ETS2 predicts poor prognosis in acute myeloid leukemia and may guide treatment decisions

Abstract Background ETS2 is a downstream effector of the RAS/RAF/ERK pathway, which plays a critical role in the development of malignant tumor. However, the clinical impact of ETS2 expression in AML remains unknown. Methods In this study, we evaluated the prognostic significance of ETS2 expression...

Full description

Bibliographic Details
Main Authors: Lin Fu, Huaping Fu, Qingyun Wu, Yifan Pang, Keman Xu, Lei Zhou, Jianlin Qiao, Xiaoyan Ke, Kailin Xu, Jinlong Shi
Format: Article
Language:English
Published: BMC 2017-07-01
Series:Journal of Translational Medicine
Subjects:
ETS2
Prognosis
AML
Allogeneic HCT
Online Access:http://link.springer.com/article/10.1186/s12967-017-1260-2

Internet

http://link.springer.com/article/10.1186/s12967-017-1260-2

Similar Items